Isomorphic Labs announces that it has entered into an agreement to expand its strategic research collaboration with Novartis. This follows the announcement of IsoLabs’ research collaboration with Novartis on 7 January, 2024. Under the terms of the agreement, IsoLabs and Novartis will expand the scope of the initial collaboration, adding up to three additional research programs on the same financial terms as the original agreement. This expansion is testament to the great collaboration and progress of research programs made in one year.
Read more in the news release below.
